Please assess the completion status of the following clinical trial:

Trial Title: Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Medically eligible healthy men and women between the ages of 20 to 49 years old.~Exclusion Criteria:~* A medical condition that places them at high risk for complications from influenza, including those with chronic heart or lung disease, such as asthma or reactive airway disease; people with medical conditions such as diabetes or kidney failure; or people with illnesses that weaken the immune system, or who take medications that can weaken the immune system.~* A history of Guillain-Barré Syndrome that occurred after receiving influenza vaccine~* Currently pregnant~* Have a severe allergy to chicken eggs or who are allergic to any of the nasal spray vaccine components~* Have had flu within the current flu season.~* Have had a flu vaccine within the current flu season.~* Have close contact with someone whose immune system is so weak they require care in a protected environment (such as bone marrow transplant unit).

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Live Attenuated Influenza Vaccine (Type: EXPERIMENTAL): Single intervention study- all participants will receive LAIV instead of injectable flu vaccine.

Based on this trial design, predict the completion outcome and termination type (if applicable).